ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2177

Specificity of Spinal Pain Features in Assessment and Classification of Spondyloarthritis

Sjef Van Der Linden1, Heinz Baumberger2 and Muhammad Asim Khan3, 1Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 2N.A., Swiss Ankylosing Spondylitis Patient Society, 7017 Flims Dorf, Switzerland, 3Medicine/ Rheumatology, Case Western Reserve Univ, Cleveland, OH

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Ankylosing spondylitis (AS), Back pain, classification criteria, epidemiologic methods and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Epidemiology and Public Health - Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Classification criteria lacking specificity cause inclusion of many false positives in settings with low prevalence of disease. The ASAS axial spondyloarthritis (axSpA) criteria have 84% specificity. If the prevalence of axSpA among chronic back pain (CBP) patients is 5% one expects 3.6 false positively labeled persons for each true axSpA patient. Back pain is a key issue in the classification of axSpA. Our aim is to assess the specificity of spinal pain features to obtain better performance of the ASAS criteria.

Methods: We assessed (1) low back pain or stiffness; (2) thoracic inter-scapular back pain or stiffness; (3) frontal chest pain or discomfort by analyzing data from two earlier studies.1,2 Inflammatory back pain (IBP) is defined as 4 or 5 Calin criteria: onset of back discomfort ≤ age 40; insidious onset; persistence for ≥ 3 months; morning stiffness; improvement with exercises. In the first study1, 739 apparently healthy leisure time sportsmen (orienteers) completed a detailed questionnaire on spinal and chest pain features. AxSpA is assumed to be absent in this group. The second study2 (a Swiss family study on AS) enabled assessing specificity of chest and back pain features in B27- first degree relatives of 275 B27+ AS patients. All (both B27+ and B27-) participants underwent clinical exam, full HLA-typing, radiography of SI joints and completed questionnaires, including chest and spinal pain features. Pelvic x-rays were blindly read, twice by each of 2 investigators. They agreed in 95.6% (kappa 66.4).

Results: The table shows the specificities for the sportsmen. The 3 pain syndromes were highly associated (p<0.001). Low back pain ever is age related. The specificity in the age groups 10-19, 20-29, 30-39, 40-49, 50-59 year are 70.1%, 46.3%, 52.1%, 42.8%, and 37.1% respectively. Altogether 24.1% of back pain ever can be classified as chronic IBP. The specificity of diagnostic spinal x-rays is 67.5%. Radiographs were done in 25% (6/24) in people with IBP < 3 months duration, but in 67 % (40/60) of people with ≥ 3 months IBP. Specificity was 99.1% for not using analgesics because of back pain ≤ last 6 months. The likelihood ratio for having had a diagnostic spinal radiograph is 2.2 (46/84:67/264) if chronic IBP is present compared to absent. Specificity was very high (99.1%) for not using analgesics because of back pain ≤ last 6 months. AS or sacroiliitis was found in 20/274 (7.3%) B27+ relatives. Sacroiliitis was never observed in B27-  relatives with IBP. Of note B27+ relatives without sacroiliitis have more often chest pain and IBP than B27- relatives suggesting axSpA or spondylitic disease in B27+ relatives.2 The specificities for the B27- relatives are shown in the table.

Conclusion: Better knowledge of specificity of spinal pain syndromes may help improving performance of classification criteria for axSpA. Chest pain and use of analgesics seem promising candidate variables.

 

Spinal Pain Syndrome  

Orienteers1

% specificity

 (n=739)

B27- Relatives

% specificity       (n=248)

B27- Relatives

% positive

(n=248)

B27+  SI-Relatives

% positive

(n=248)

mean age (yr)

32.7

28.7

28.7

28.0

males (%)

64.4

48.0

48.0

41.5

 

 

 

 

 

Low back pain ever

52.9

41.1

58.9

62.5

Inflammatory back pain

89.1

89.5

10.5^

16.1^

Onset < 40 yr

21.6

48.0

52.0

57.7

Insidious onset

44.5

69.0

31.0

27.8

Duration > 3 months

69.5

87.3

12.7

15.0

Morning stiffness

62.6

79.8

20.2

27.0

Improvement

with exercises

41.7

81.3

18.7

18.6

Chest pain or discomfort2

91.5

93.4

  6.6*

14.9*

Thoracic pain or discomfort

85.4

89.4

10.6#

13.5#

1Scan J Rheumatol 1988;17:475-81

2J Rheumatol 1988;15;836-9

^ 0.10 < p < 0.05

*p < 0.01

# p > 0.05

              


Disclosure: S. Van Der Linden, None; H. Baumberger, None; M. A. Khan, None.

To cite this abstract in AMA style:

Van Der Linden S, Baumberger H, Khan MA. Specificity of Spinal Pain Features in Assessment and Classification of Spondyloarthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/specificity-of-spinal-pain-features-in-assessment-and-classification-of-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/specificity-of-spinal-pain-features-in-assessment-and-classification-of-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology